Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Leap Therapeutics Inc (LPTX)

Leap Therapeutics Inc (LPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Crypto coins by Kanchanara via Unsplash
Cypherpunk Stock Soars on Zcash Rebrand. Should You Buy the Crypto Penny Stock Here? Barchart - Fri Nov 14, 2025

Cypherpunk Technologies soars as it transforms from a biotech firm to a Zcash treasury company. But several risks warrant taking profit in CYPH stock at current levels.

CYPH : 0.5743 (+1.14%)
^ZECUSD : 210.9670 (-6.09%)
^BTCUSD : 70,378.66 (+0.18%)
LPTX : 2.0500 (+368.57%)
Crypto coins by Kanchanara via Unsplash
This Penny Stock Is Pivoting to the Zcash Crypto. Should You Buy Shares After Its November 13 Rebrand? Barchart - Thu Nov 13, 2025

Leap Therapeutics stock skyrockets as the company announces a ZCash-focused crypto treasury strategy. But the strategic pivot is coupled with substantial risks that warrant caution on LPTX shares.

^ZECUSD : 210.9670 (-6.09%)
LPTX : 2.0500 (+368.57%)
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results PR Newswire - Wed Nov 12, 2025

CAMBRIDGE, Mass. , Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel therapies for patients with cancer...

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy PR Newswire - Wed Nov 12, 2025

Khing Oei appointed Chairman of the Board; Will McEvoy appointed Chief Investment Officer and Member of the Board; Cypherpunk Technologies Inc. announces acquisition of 203,775.27...

CYPH : 0.5743 (+1.14%)
LPTX : 2.0500 (+368.57%)
Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy PR Newswire - Wed Nov 12, 2025

Khing Oei appointed Chairman of the Board; Will McEvoy appointed Chief Investment Officer and Member of the Board; Cypherpunk Technologies Inc. announces acquisition of 203,775.27...

CYPH : 0.5743 (+1.14%)
LPTX : 2.0500 (+368.57%)
Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025 PR Newswire - Mon Oct 20, 2025

Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high population

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy PR Newswire - Thu Oct 9, 2025

CAMBRIDGE, Mass. , Oct. 9, 2025 /PRNewswire/ -- Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has...

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Announces $58.88M Private Placement Tipranks - Tue Oct 7, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Leap Therapeutics...

LPTX : 2.0500 (+368.57%)
Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy PR Newswire - Mon Oct 6, 2025

CAMBRIDGE, Mass. , Oct. 6, 2025 /PRNewswire/ -- Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced $58,888,888...

LPTX : 2.0500 (+368.57%)
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion FinancialNewsMedia - Mon Oct 6, 2025

EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:LPTX),(NASDAQ:IOBT),(NASDAQ:CELC),(NYSE:MAIA) EQNX::TICKER_END

CELC : 115.33 (-1.51%)
GTBP : 0.4018 (-3.51%)
IOBT : 0.2541 (-4.37%)
LPTX : 2.0500 (+368.57%)
MAIA : 1.5200 (+1.33%)

Barchart Exclusives

Should You Buy Vertiv Stock Before March 23? Barchart - 8 minutes ago
Vertiv stock surged to an all-time high on news of its inclusion in the S&P 500. Here's what investors need to know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot